Indian pharma compliance standards improving, regulatory risks here to stay: Ind-Ra
Jul 07, 2020
Mumbai (Maharashtra) [India], July 7 : Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of...